Guardant Health Inc (GH)

$88.75 +1.57 (1.80%)
Market Cap 11.21B
Revenue (ttm) 982.02M
Net Income (ttm) -416.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -42.39%
Debt to Equity Ratio -15.14
Volume 1,167,200
Avg Vol 2,051,086
Day's Range N/A - N/A
Shares Out 131.17M
Stochastic %K 46%
Beta 1.67
Analysts Strong Sell
Price Target $134.50

Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling t...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 855 698 8887
Fax: 888 974 4258
Address:
3100 Hanover Street, Palo Alto, United States
Cutlass
Cutlass Mar. 16 at 1:19 PM
$GH Been dropping for 8 weeks now - Will wait, on watch 👀
1 · Reply
Gator5326
Gator5326 Mar. 16 at 1:03 PM
$GH How awesome is $GH? “By being the first insurer in Asia to offer the Shield MCD test, we’re empowering our customers with a credible and valued service that encourages proactive health management,” said Steve Finch, President and CEO of Manulife Asia. “This exclusive partnership demonstrates our commitment to offering innovative and differentiated solutions to improve the health outcomes of our customers.”
0 · Reply
StockNews_Live
StockNews_Live Mar. 16 at 12:21 PM
$GH 🎯 STOCK NEWS ALERT 💵 Price: $85.52 (+1.75%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Guardant Health announced the launch of the Shield multi-cancer detection (MCD) laboratory developed test in multiple markets in Asia, including Hong Kong, Singapore, and the Philippines. Eligible… 📎 https://stocknews.live/news/GH/guardant-health-launches-shield-01663.html
0 · Reply
Gator5326
Gator5326 Mar. 16 at 12:14 PM
$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIA8n6vjeFh7ltQM-2FMG941fInP13SAcMpRo6VDsnUg7wblttRy5hVbEExlnHG1xLYP4F7XhCPe6vj6Eqx3RMAN8lvT6sMgbaDJim-2FJ3hpO8MVblQwC-2F75wUn30yHteYUQZgaJ4DtTX6zbkXHC3G7fHjipE0KJW26gDHiuKCoNregYQ-3DeWLb_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMi-2FR4SgqcBs7yQ0n-2F4ewtV-2FoySDDLHo55fynoKdW-2FF8L2AP41DZU8YxMc5jJngulijGCo4ufujXTXqs5zQKf4ABhdVsaTKWqDj2U5u8B22GvnAbXECVsb1d83ip4se7iRxEJtoiX2-2BboDSJBtwMZFkNQltlxB-2BWzVnSvuaVshJIo5kjCu-2B56EiFHir6kWZnVOWGKCzgn-2BqVgLNFvO4D5sNUdlsSvfeQMWNEj2m2HqKE7qwgL9cbAux-2FmHOnDZ8f5xMnx2nD5XsA7L0ds8lR997EJ4rWV-2B8tmz6fIu6ByIgTSJYjR12gWVthfvjNbg2Mrog-3D-3D
0 · Reply
Gator5326
Gator5326 Mar. 13 at 8:41 PM
$GH https://m.facebook.com/story.php?story_fbid=pfbid02F7c781W1Cpy6zKY8ko9Lm7DPSGHhmSJ4Lb6wi7bD9f74GtC4dNbPCbDL4QARferhl&id=100044244079017
0 · Reply
Gator5326
Gator5326 Mar. 13 at 12:12 PM
$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyc0ykOikWEhSXYW21xyo5BdQN35uOTs4e7SRVbKJrb8qqHmK9yVCU4R4OX1GhDmqkgXZjS9ywBPtvYt16xmVBD5MGzzYjyqIpDxYb0sUmINArAMnFB0IodpoXW5FulLy4r6l1iBKWaS02pM-2BE25dJYkXwvcZQYJH6yVqoCCen0dqjbJdX2H-2B3X8AXCiWBB1xNeZDRUmNAwpQf1a4VGFycve-2Few3HjlyzHNvUu0WzNQXRjSnNoVaE7n1KD-2FqdWwUDkY-3DI3Hf_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRaWxdbhNYu4J6vtCfFut8RKM6aMY3xxO09R1HfVxhAsH6qUmo2jAgLi2Ejzky02-2B1-2Bfdy82ibTWoWWv7E-2Fp9obLiSHe8Txnezpfe7ekSBSyKlVN-2BkbNa2njSnruPZEKDbhxqK-2Bw-2FRaEt9ycuFNtEI9diHACLr9vnOHwaUwIv16MScV38nmCgrjN4mcrKgdjhRDXpRjIDI1Z159HuckffsGXfjMhesMS2aysuTBl-2BSN3R5qmzS9kZhmY2hFnnc9Zs-2BA0wyTdQ24X9qagOAtguWkVkFxs2OdL-2B4tIU67i5oazXFcVyySaLHifdCUZ4JFwbaqk-2BHyFmVc4IsU3urJV0ToEotL8wON3JUzs5a3EtI5x-2FBVdxij91kMYAbt3j9ppzhAVdoumd8Hh8F-2B16I0JvgQ-3D-3D
1 · Reply
123rs123
123rs123 Mar. 13 at 8:03 AM
$GH market gifted us with an insane discount, instabuy at these levels
1 · Reply
GoldenBum77
GoldenBum77 Mar. 12 at 5:08 PM
$GH Can anyone explain how this went from $120 to $83 on only good news?
1 · Reply
_TP888
_TP888 Mar. 12 at 4:44 PM
$GH | $80.00 | Put | Premium: $1.05M Ask-heavy - aggressive put buyers.
0 · Reply
thingkfast
thingkfast Mar. 11 at 11:56 PM
$GH gap fill?
1 · Reply
Latest News on GH
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership

Mar 16, 2026, 8:05 AM EDT - 1 day ago

Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership

New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare

Mar 13, 2026, 8:05 AM EDT - 4 days ago

New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare

Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

Mar 10, 2026, 8:05 AM EDT - 7 days ago

Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America

Mar 4, 2026, 7:00 AM EST - 13 days ago

Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America

Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened

Mar 3, 2026, 7:00 AM EST - 14 days ago

Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 27, 2026, 4:05 PM EST - 18 days ago

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Feb 19, 2026, 4:05 PM EST - 26 days ago

Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open

Feb 12, 2026, 2:35 PM EST - 4 weeks ago

Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open

Guardant Health to Participate in Upcoming Investor Conferences

Feb 3, 2026, 4:05 PM EST - 6 weeks ago

Guardant Health to Participate in Upcoming Investor Conferences

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions

Feb 2, 2026, 8:05 AM EST - 6 weeks ago

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions

Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Jan 29, 2026, 4:05 PM EST - 6 weeks ago

Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer

Jan 22, 2026, 12:51 PM EST - 7 weeks ago

FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer

Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Jan 22, 2026, 8:05 AM EST - 7 weeks ago

Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform

Jan 19, 2026, 8:05 AM EST - 2 months ago

Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results

Jan 11, 2026, 5:00 PM EST - 2 months ago

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results

Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families

Jan 8, 2026, 8:05 AM EST - 2 months ago

Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families

Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 4:05 PM EST - 2 months ago

Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening

Dec 29, 2025, 10:10 AM EST - 2 months ago

Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening

Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.

Dec 11, 2025, 8:05 AM EST - 3 months ago

Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.

Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

Dec 9, 2025, 8:05 AM EST - 3 months ago

Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium

Dec 5, 2025, 8:05 AM EST - 3 months ago

Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium

Senator Buys Coca-Cola, Hershey's Stock After Selling Magnificent Seven Stocks In 2025

Dec 2, 2025, 7:23 PM EST - 3 months ago

Senator Buys Coca-Cola, Hershey's Stock After Selling Magnificent Seven Stocks In 2025

HSY KO

These 15 stocks are still showing momentum — and a market-beating edge

Nov 20, 2025, 3:45 PM EST - 4 months ago

These 15 stocks are still showing momentum — and a market-beating edge

BE CIEN CRDO INSM LITE MP MU

6 Healthcare Stocks With Strong Upward Momentum

Nov 18, 2025, 12:59 PM EST - 4 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN MEDP WGS

Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access

Nov 12, 2025, 8:05 AM EST - 4 months ago

Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access

Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring

Nov 10, 2025, 8:05 AM EST - 4 months ago

Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring

New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy Response

Nov 6, 2025, 8:05 AM EST - 4 months ago

New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy Response

Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients

Nov 5, 2025, 4:05 PM EST - 4 months ago

Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients

Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering

Nov 5, 2025, 2:15 AM EST - 4 months ago

Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering

Guardant Health Announces Pricing of Upsized Public Offering of Common Stock

Nov 5, 2025, 2:15 AM EST - 4 months ago

Guardant Health Announces Pricing of Upsized Public Offering of Common Stock

Guardant Health Announces Proposed Public Offering of Common Stock

Nov 4, 2025, 4:39 PM EST - 4 months ago

Guardant Health Announces Proposed Public Offering of Common Stock

Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033

Nov 4, 2025, 4:38 PM EST - 4 months ago

Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033

Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Oct 29, 2025, 4:05 PM EDT - 4 months ago

Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights

Oct 27, 2025, 8:05 AM EDT - 5 months ago

Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025

Oct 26, 2025, 3:01 PM EDT - 5 months ago

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025

Oct 15, 2025, 4:57 PM EDT - 5 months ago

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025

Oct 9, 2025, 4:05 PM EDT - 5 months ago

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025

FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer

Sep 29, 2025, 8:05 AM EDT - 6 months ago

FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United States

Sep 24, 2025, 8:05 AM EDT - 6 months ago

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United States

DGX

Alex M. Azar II Joins Guardant Health Board of Directors

Sep 15, 2025, 4:07 PM EDT - 6 months ago

Alex M. Azar II Joins Guardant Health Board of Directors

Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership

Sep 11, 2025, 8:05 AM EDT - 6 months ago

Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership

Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States

Sep 8, 2025, 8:05 AM EDT - 6 months ago

Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States

Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test

Sep 4, 2025, 8:06 AM EDT - 6 months ago

Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test

Guardant Health to Host Investor Day on September 24, 2025

Aug 28, 2025, 4:05 PM EDT - 7 months ago

Guardant Health to Host Investor Day on September 24, 2025

Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 26, 2025, 4:05 PM EDT - 7 months ago

Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity

Aug 4, 2025, 8:06 AM EDT - 8 months ago

American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity

Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 31, 2025, 4:05 PM EDT - 8 months ago

Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference

Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings

Jul 31, 2025, 2:10 PM EDT - 8 months ago

Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings

Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Jul 30, 2025, 4:05 PM EDT - 8 months ago

Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+

Jul 30, 2025, 8:09 AM EDT - 8 months ago

Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+

Cutlass
Cutlass Mar. 16 at 1:19 PM
$GH Been dropping for 8 weeks now - Will wait, on watch 👀
1 · Reply
Gator5326
Gator5326 Mar. 16 at 1:03 PM
$GH How awesome is $GH? “By being the first insurer in Asia to offer the Shield MCD test, we’re empowering our customers with a credible and valued service that encourages proactive health management,” said Steve Finch, President and CEO of Manulife Asia. “This exclusive partnership demonstrates our commitment to offering innovative and differentiated solutions to improve the health outcomes of our customers.”
0 · Reply
StockNews_Live
StockNews_Live Mar. 16 at 12:21 PM
$GH 🎯 STOCK NEWS ALERT 💵 Price: $85.52 (+1.75%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Guardant Health announced the launch of the Shield multi-cancer detection (MCD) laboratory developed test in multiple markets in Asia, including Hong Kong, Singapore, and the Philippines. Eligible… 📎 https://stocknews.live/news/GH/guardant-health-launches-shield-01663.html
0 · Reply
Gator5326
Gator5326 Mar. 16 at 12:14 PM
$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIA8n6vjeFh7ltQM-2FMG941fInP13SAcMpRo6VDsnUg7wblttRy5hVbEExlnHG1xLYP4F7XhCPe6vj6Eqx3RMAN8lvT6sMgbaDJim-2FJ3hpO8MVblQwC-2F75wUn30yHteYUQZgaJ4DtTX6zbkXHC3G7fHjipE0KJW26gDHiuKCoNregYQ-3DeWLb_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMi-2FR4SgqcBs7yQ0n-2F4ewtV-2FoySDDLHo55fynoKdW-2FF8L2AP41DZU8YxMc5jJngulijGCo4ufujXTXqs5zQKf4ABhdVsaTKWqDj2U5u8B22GvnAbXECVsb1d83ip4se7iRxEJtoiX2-2BboDSJBtwMZFkNQltlxB-2BWzVnSvuaVshJIo5kjCu-2B56EiFHir6kWZnVOWGKCzgn-2BqVgLNFvO4D5sNUdlsSvfeQMWNEj2m2HqKE7qwgL9cbAux-2FmHOnDZ8f5xMnx2nD5XsA7L0ds8lR997EJ4rWV-2B8tmz6fIu6ByIgTSJYjR12gWVthfvjNbg2Mrog-3D-3D
0 · Reply
Gator5326
Gator5326 Mar. 13 at 8:41 PM
$GH https://m.facebook.com/story.php?story_fbid=pfbid02F7c781W1Cpy6zKY8ko9Lm7DPSGHhmSJ4Lb6wi7bD9f74GtC4dNbPCbDL4QARferhl&id=100044244079017
0 · Reply
Gator5326
Gator5326 Mar. 13 at 12:12 PM
$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyc0ykOikWEhSXYW21xyo5BdQN35uOTs4e7SRVbKJrb8qqHmK9yVCU4R4OX1GhDmqkgXZjS9ywBPtvYt16xmVBD5MGzzYjyqIpDxYb0sUmINArAMnFB0IodpoXW5FulLy4r6l1iBKWaS02pM-2BE25dJYkXwvcZQYJH6yVqoCCen0dqjbJdX2H-2B3X8AXCiWBB1xNeZDRUmNAwpQf1a4VGFycve-2Few3HjlyzHNvUu0WzNQXRjSnNoVaE7n1KD-2FqdWwUDkY-3DI3Hf_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRaWxdbhNYu4J6vtCfFut8RKM6aMY3xxO09R1HfVxhAsH6qUmo2jAgLi2Ejzky02-2B1-2Bfdy82ibTWoWWv7E-2Fp9obLiSHe8Txnezpfe7ekSBSyKlVN-2BkbNa2njSnruPZEKDbhxqK-2Bw-2FRaEt9ycuFNtEI9diHACLr9vnOHwaUwIv16MScV38nmCgrjN4mcrKgdjhRDXpRjIDI1Z159HuckffsGXfjMhesMS2aysuTBl-2BSN3R5qmzS9kZhmY2hFnnc9Zs-2BA0wyTdQ24X9qagOAtguWkVkFxs2OdL-2B4tIU67i5oazXFcVyySaLHifdCUZ4JFwbaqk-2BHyFmVc4IsU3urJV0ToEotL8wON3JUzs5a3EtI5x-2FBVdxij91kMYAbt3j9ppzhAVdoumd8Hh8F-2B16I0JvgQ-3D-3D
1 · Reply
123rs123
123rs123 Mar. 13 at 8:03 AM
$GH market gifted us with an insane discount, instabuy at these levels
1 · Reply
GoldenBum77
GoldenBum77 Mar. 12 at 5:08 PM
$GH Can anyone explain how this went from $120 to $83 on only good news?
1 · Reply
_TP888
_TP888 Mar. 12 at 4:44 PM
$GH | $80.00 | Put | Premium: $1.05M Ask-heavy - aggressive put buyers.
0 · Reply
thingkfast
thingkfast Mar. 11 at 11:56 PM
$GH gap fill?
1 · Reply
Gator5326
Gator5326 Mar. 11 at 5:55 PM
$GH ACS fireworks coming soon!
0 · Reply
Gator5326
Gator5326 Mar. 10 at 5:33 PM
$GH Another great call. 2026 and beyond! $GH firing on all cylinders! 😎
0 · Reply
Gator5326
Gator5326 Mar. 10 at 1:11 PM
$GH 3 years ago I asked my GP if he heard of $GH during my yearly. He had not. Last year I asked him again and he said yes, it was third option 1. Colonoscopy 2. Cologuard 3. Shield. I can’t wait to ask him this year, lol.
1 · Reply
Gator5326
Gator5326 Mar. 10 at 12:34 PM
$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIAEdU5tJ99oTUxybcxc4sOAbM9AyQjFo2c-2BTr2ia50GjKmPPYxomUe1b7ucKEJOL-2BuAfDncFXAjkSR8y7b4y4oGCMigQjyE99n-2BhsipciN-2BdexjVR4G0ECvhcASCRcDRb43LnWHvUplTY2oU4Wf0X8We2Megou0mDfisvASfWGiRJ3sJkmfDPU3VugDysotRVWdk8Rx434dGlOqTpnyEKXGtwd2kknPxm206PNWYMvdqA-3DKeKO_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMlqn-2Fk-2FrM2GYqDRMerLL-2F95FJmGGB9VrBIZamHiBbTuGHTK6j4AgnYmGyqHxllQ9W8H5dcnwrQxgcdMhc5gXVdV8J5lSTb56UOGzIyCVqngeoEairXH145U7cBA0aT5BHkphVMEPKxyXVjqkpjCxkG08lA3nNiHrb2IKtCG326F8hok2G8t6xOkhdaSDmZP5TnOjDsr4gAsFEF7n-2BCa5NkSmUbNBKaFAI2jqY30KIgNbCmVFNfQmHcZOs-2FyNjnbxGegzJFAEAx-2BwPXGAho-2BFDH96riA9Tl8DJLPBg4t8BEYgzv-2BE4Fx7XzddnV-2BSUzK67WbWth2xoublLAn4eKxML3P-2BSVRTogXqEzU8Urv5aQKTckiDnpOSMQA2cPJk8mTpCw-3D-3D
0 · Reply
StockNews_Live
StockNews_Live Mar. 10 at 12:05 PM
$GH 🎯 STOCK NEWS ALERT 💵 Price: $91.17 (+0.00%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Guardant Health, Inc. announced a strategic collaboration with Quest Diagnostics to enable streamlined and accelerated access to the Shield blood-based colorectal cancer screening test across Quest's… 📎 https://stocknews.live/news/GH/guardant-health-s-shield-67082.html
0 · Reply
ZacksResearch
ZacksResearch Mar. 5 at 5:10 PM
$GH vs $BIAF: Why Guardant Health Looks More Compelling Now! 📈 📊 GH surged 131.6% in the past year, while BIAF plunged 90.9%! 🧬 GH's strategic collaborations and expanding product portfolio drive its strong market position. 💰 BIAF trades at a deep discount relative to its historical range and the broader medical sector but faces growth uncertainty despite promising tech. Find out why GH is the preferred pick 👉 https://www.zacks.com/stock/news/2879579/biaf-vs-gh-which-cancer-detection-stock-is-the-better-buy-now?cid=sm-stocktwits-2-2879579-body-36157&ADID=SYND_STOCKTWITS_TWEET_2_2879579_BODY_36157
0 · Reply
ZacksResearch
ZacksResearch Mar. 5 at 4:10 PM
$BIAF vs. $GH — two cancer detection plays, two very different strategies. Which one has the edge right now? 👀 bioAffinity is leaning on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health is expanding across liquid biopsy and screening. Focused niche vs. broader platform — that’s the real debate. Which model wins from here? Full head-to-head breakdown 👉 https://www.zacks.com/stock/news/2879579/biaf-vs-gh-which-cancer-detection-stock-is-the-better-buy-now?cid=sm-stocktwits-2-2879579-teaser-36148&ADID=SYND_STOCKTWITS_TWEET_2_2879579_TEASER_36148
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 4 at 6:48 PM
$GH Current Stock Price: $94.46 Contracts to trade: $95.0 GH Mar 20 2026 Call Entry: $4.20 Exit: $8.04 ROI: 91% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Gator5326
Gator5326 Mar. 4 at 12:40 PM
$GH The life changing blood test is hitting the road! https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIAgqhDD8V3BueGRIC1Xdy0LPaSZUGPwxugQ7hM-2FJ6YYEJTD6SIPCrnX-2B56l-2BGginPZDjIjEUkU3tAxdjZ34Tl6QS1zKieevMZiNOT3TYzndjoS7ePyjDhKk9KUcFm8rkfC28vFI8vGkv-2FQrfCcpi6laHVJ5zerP0BUDKNHKd6A4b2JhiukTdh2thhjktXV4Wk39Ke-_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMiv-2B389NpYl8Q7dFQBOwtJP-2By8CsWZiNvJR0fyQuSktTEi0029lm9qIVaumvVjZcuKRi28IS-2BD-2BpntUpbQhBYZ7zOQ2Qkvf0A0T3vRV-2FlVK3KW8u38D2Chp2i9w-2B12zjjVrOeazahFPdcyTn9GMsk3yDkRXWk4QgcZ0PzM3N8NQhZ2CYUwufZHTw1qPcTqb2sxvarm00ZIcR-2Fixt0dLOM-2B8FnDRlU0zpUz8JqGZsHcG00A-2Fmt6-2BpkgjwCMJwgzB2mx3oOCOPsP3TOvkFrgJ-2BOj9qZZZ3xyG2dj7ody75NSxCxHdpBPy8wxQ0Ns67ukPZtYtDRxWsQLmCbj7hiTtXdXo-3D
0 · Reply
Gator5326
Gator5326 Mar. 4 at 11:39 AM
$GH $GH on CBS https://www.cbsnews.com/video/patrick-dempsey-advocates-for-colorectal-cancer-awareness-and-talks-friendship-with-eric-dane/
0 · Reply
JasonCO
JasonCO Mar. 3 at 8:21 PM
$GH nice move from $88. Send it
0 · Reply
WallStJesus
WallStJesus Mar. 3 at 7:16 PM
$GH UNUSUAL BUYER DETECTED IN THE HEALTHCARE PLAY
0 · Reply